Paul Douglas Burgess
Chief Operating & Business OfficerMr. Paul Douglas Burgess, J.D., M.S, serves as Chief Operating Officer and Chief Business Officer at Kailera Therapeutics, Inc. since September 2024. He serves as Chief Business Development & Strategic Operations Officer at Cerevel Therapeutics Holdings, Inc. since June 20, 2023. He served as Chief Operating Officer of Translate Bio, Inc. since December 2019 and also serves as its Chief Legal Officer since June 2018. He served as Secretary at Translate Bio, Inc. Mr. Burgess served as General Counsel at Translate Bio, Inc. from May 2016 to June 2018. Mr. Burgess served as Vice President of Intellectual Property at Scholar Rock, Inc., since March 2015 until May 19, 2016. Mr. Burgess served as Head of Intellectual Property and legal counsel at Civitas Therapeutics, Inc. Mr. Burgess served as Vice President of Intellectual Property at DNIB Unwind, Inc. (BIND Therapeutics, Inc). since March 2011. He served as Director of Intellectual Property of Logical Therapeutics, Inc. He has experience in the biotech and pharmaceutical industry with expertise managing all aspects of intellectual property portfolios. Prior to joining Civitas, he served as General Counsel and Head of Intellectual Property at Logical Therapeutics. He served as Senior Patent Counsel at Johnson & Johnson. He served as Patent Counsel at Transform Pharmaceuticals and a scientist at Genetics Institute. Mr. Burgess has designed and implemented the patent strategy for two pharmaceutical products being sold worldwide. He received a JD from Northeastern University, an MS in pharmacology from Northeastern University and a BS in biology from Merrimack College.
Positions
- Company NameKailera Therapeutics, Inc.Stock CodeKLRAPositionChief Operating & Business OfficerColleagues
- RCRonald C. RenaudPresident, CEO & Director
- JFJohn F. MilliganIndependent Non-Employee Chairman
- JBJamie Beth ColemanChief Commercial Officer
- DWDouglas W. PaganChief Financial Officer
- MGMaura GavaghanVice President of Corporate Communications & Investor Relations
- ATAndrew T. KaplanIndependent Non-Employee Director
- CHChristopher HiteIndependent Non-Employee Director
- FKFranklin K. ClyburnIndependent Non-Employee Director
